The study of albumin dialysis efficiency in acute liver failure using the «Bioartificial liver» device

Cover Page


Cite item

Abstract

Aim. Clinical testing of albumin dialysis method in patients with acute liver failure of different etiologies on the experimental sample of the «bioartificial liver» device.

Methods. Clinical assessment of treatment using the «bioartificial liver» device was conducted on 20 patients aged 22-68 years old who had acute liver failure of different etiology. The «bioartificial liver» device consisted of a perfusion unit, the dialyzer, dialysis circuit with albumin solution and carbon haemosorbent mode. A 10% donor human albumin solution was used as the dialysis fluid in recirculation mode. For restoration of the accepting ability albumin was exposed to perfusion through the carbonic hemosorbent. Duration of the treatment was 3 hours, control of liver damage biochemical markers was performed before and after the session.

Results. There was a statistically significant reduction in biochemical markers of cytolysis and cholestasis: transaminases, alkaline phosphatase and bilirubin levels. We also observed a statistically significant reduction of ammonia level, which is one of the main clinical and laboratory signs characterizing the severity of encephalopathy. Improvement of liver synthetic function reflected a statistically significant increase in glucose level. Clinical stabilization as well as reduction of encephalopathy clinical signs were observed after the procedure. No side effects were notices.

Conclusion. Implementation of albumin dialysis in patients with acute liver failure using the «bioartificial liver» device was accompanied by an improvement of their functional state. This gives reason to use this method for the treatment of acute liver failure in intensive care units.

About the authors

E E Polevshchikova

South Ural State Medical University, Chelyabinsk, Russia

Author for correspondence.
Email: caramella-a@mail.ru

References

  1. Гастроэнтерология и гепатология: диагностика и лечение / Под. ред. А.В. Калинина, А.И. Хазанова. - М.: Миклош, 2007. - 600 с.
  2. Ивашкин В.Т. Болезни печени и желчевыводящих путей. - М.: Изд. дом М-Вести, 2002. - 416 с.
  3. Кутепов Д.Е., Пасечник И.Н., Миронов Н.П. и др. Клиническая эффективность альбуминового диализа в терапии больных с гепаторенальным синдромом // Вестн. трансплантол. и искусственных органов. - 2009. - Т. XI, №4. - С. 51-56.
  4. Луйк А.И., Лукьянчук В.Д. Сывороточный альбумин и биотрансформация ядов. - М.: Медицина, 1984. - 217 с.
  5. Пасечник И.Н., Кутепов Д.Е. Печёночная недостаточность. - М.: МИА, 2009. - 235 с.
  6. Полевщикова Е.Е., Рябинин В.Е., Томилов А.Г. и др. «Биоискусственная печень»: эффективность и безопасность использования альбумин-диализа в режиме рециркуляции через углеродный сорбент // Извест. Челяб. науч. центра УрО РАН. - 2004. - Спец. вып. №25. - С. 40-44.
  7. Рябинин В.Е., Полевщикова Е.Е. Аппарат для диализа. Патент на полезную модель №56191 РФ от 10.09.2006.
  8. Рябинин В.Е., Супрун В.И., Ткачёв С.И. Использование искусственных систем жизнеобеспечения и клеточных технологий при лечении заболеваний печени. - Челябинск, 2007. - 131 с.
  9. Рябинин В.Е., Полевщикова Е.Е., Супрун В.И., Егоров А.П. Аппарат для альбуминовой и цитозольной детоксикации // Мед. техника. - 2014. - №3. - С. 14-17.
  10. Хорошилов С.Е., Гранкин В.И., Скворцов С.В. и др. Лечение острой печёночной и печёночно-почечной недостаточности с применением альбуминового диализа на аппарате MARS // Рос. ж. гастроэнтерол., гепатол., колопроктол. - 2006. - Т. 16, №2. - С. 49-54.
  11. Faria L.C., Ychai P., Saliba F. et al. Etiology, outcome and early causes of death in 427 patients with acute liver failure (ALF): A 20 year single-center experience // J. Hepatol. - 2006. - Vol. 44, suppl. 2. - P. 61. http://dx.doi.org/10.1016/S0168-8278(06)80140-6
  12. Heise M., Lang H. Gender-specific differences in liver transplantation // Zentralblatt fur Chirurgie. - 2015. - Vol. 140, N 3. - P. 279-284. http://dx.doi.org/10.1055/s-0035-1546123
  13. Parekh P.J., Balart L.A. Ammonia and its role in the pathogenesis of hepatic encephalopathy // Clin. Liver Dis. - 2015. - Vol. 19, N 3. - P. 529-537. http://dx.doi.org/10.1016/j.cld.2015.05.002
  14. Ryabinin V.E. Problems and prospects of creation of extracorporal systems for support of the functional state of the liver // Biochemistry (Moscow). Supplement series B: Biomedical Chemistry. - 2015. - Vol. 9, N 1. - P. 30-44. http://dx.doi.org/10.1134/S1990750815010084

© 2015 Polevshchikova E.E.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies